$TENX

Monday’s insider buys and sells: Coal director invests $3.2M

Insider trading activity reported for US public companies includes significant purchases and sales. ADAR1 Capital bought 1.03M Tenax Therapeutics (TENX) shares for $1.81M. Kenneth Courtis acquired 15K Alpha Metallurgical (AMR) shares for $3.16M. Rex Geveden bought 5K TTM Technologies (TTMI) shares for $524.5K. Ashley McEvoy, CEO of Insulet (PODD), purchased 1.1K shares for $162.2K. Notable sales include James Wirth selling IHT shares for $1.82B, Alexander Karp selling 492K Palantir (PLTR) shares

Original reporting
Published Aug 25, 2026, 1:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 1:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$TENX
Bullish
medium confidence
Mentioned
$TENX · $AMR · $TTMI · $BFC · $PODD · $IHT
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$TENXBullishLow
01

Why it matters

Aggregated insider activity provides mixed signals; large sells may pressure stocks while buys could support them.

02

Market read

The filings highlight potential short‑term price moves for the listed tickers.

03

What to watch

Some purchases could be strategic positioning ahead of upcoming corporate events not disclosed yet.

Relevance 4/10Novelty 6/10Timing: Monday

Background

Weekly roundup of Form 4 insider transactions across multiple US‑listed companies.

Company-level read

Ticker impact

$TENXBullishMedium confidence
Context

Form 4 shows insider ADAR1 Capital Management buying $1.81M of Tenax Therapeutics shares.

Expected impact

Potential modest upside as market absorbs buying signal.

Evidence & confidence

Buy amount is sizable for a micro‑cap, but price already down 84% YTD limiting upside.

$AMRBullishMedium confidence
Context

Director Kenneth S. Courtis purchased $3.16M of Alpha Metallurgical Resources shares.

Expected impact

Short‑term price lift expected.

Evidence & confidence

Purchase size relative to float is material; market may view as endorsement.

$TTMIBullishLow confidence
Context

Director Rex D. Geveden bought 5,000 shares of TTM Technologies for $524,500.

Expected impact

Limited upside; may stabilize price.

Evidence & confidence

Purchase is modest relative to market cap.

$BFCNeutralLow confidence
Context

Director Tracy C Pearson acquired 1,024 shares of Bank First Corp for $160,737.

Expected impact

Minimal impact.

Evidence & confidence

Transaction size is tiny relative to float.

$PODDBullishMedium confidence
Context

CEO Ashley McEvoy bought 1,100 shares of Insulet Corp for $162,217.

Expected impact

Potential modest rally if market interprets as confidence.

Evidence & confidence

Executive buying is a strong signal, though amount is modest.

$IHTBearishMedium confidence
Context

CEO James F. Wirth sold 34,800 shares of Innsuites Hospitality Trust worth $1.82B.

Expected impact

Downward pressure likely.

Evidence & confidence

Sale size is massive relative to market cap.

$CHYMBearishMedium confidence
Context

DST Global Advisors sold $28.1M of Chime Financial shares.

Expected impact

Potential short‑term dip.

Evidence & confidence

Sale amount is notable for a fintech of this size.

$PLTRBearishMedium confidence
Context

CEO Alexander C. Karp sold 492,348 shares of Palantir for $86.06M.

Expected impact

Possible modest decline.

Evidence & confidence

Size is material; tax‑driven sales still signal liquidity need.

Market effects

Insider activity across healthcare, fintech, mining, and REITs may influence sector sentiment.

US market focus; no notable regional spillover.

Limited to US‑listed equities.

Counterpoint

Insider sells may be routine tax planning rather than lack of confidence.

Key entities

  • Tenax Therapeutics

    Biotech micro‑cap with recent insider buying.

  • Palantir Technologies

    Data‑analytics firm with large insider sell.

Related articles

$ORCLLow

Why The Big Short's Bet Against AI Might Not Pan Out

Michael Burry, known for his 2007 real estate market bet, has short positions in Oracle (ORCL), Palantir (PLTR), and Nebius (NBIS). He reduced bets against NVDA and PLTR. Burry's options suggest an AI crash by year-end, but Nvidia's GPU deals and Hugging Face acquisition indicate strong AI demand. Palantir's government contracts may boost revenue.

$VDTAMed

Dollar Market Growing Behind the AI Revolution

The global AI infrastructure market is projected to grow from $337B in 2025 to $1.2T by 2030, according to S&P Global. Key drivers include AI inference and hardware demand. Vertical Data (VDTA) secured a $192M deal for an AI infrastructure project, while IREN (IREN), Nebius (NBIS), and Applied Digital (APLD) also reported AI-related developments.

$RMDMedAI 8/10

Patient Monitoring Stocks Q2 Teardown: ResMed (NYSE:RMD) Vs The Rest

ResMed (RMD) and peers reported Q2 earnings, with revenues beating estimates by 1.4% but next quarter's guidance below. RMD's revenue grew 8.6% YoY, meeting expectations, while iRhythm (IRTC) saw 20.1% growth, exceeding estimates. Insulet (PODD) and DexCom (DXCM) also reported, with mixed results. Stocks have declined since earnings, with RMD down 2.3% and IRTC down 13%.